Generics Global Industry Almanac 2017-2021
Summary
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Key Highlights
- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
The market value is evaluated at ex-factory prices.
Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
All currency conversions were calculated at constant average annual 2016 exchange rates.
- The global generics market had total revenues of $311.1bn in 2016, representing a compound annual growth rate (CAGR) of 9.5% between 2012 and 2016.
- Market consumption volume increased with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total pharma volume in 2016.
- Strong growth will continue in the emerging markets but worldwide there will be a deceleration.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
- Leading company profiles reveal details of key generics market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Reasons to buy
- What was the size of the global generics market by value in 2016?
- What will be the size of the global generics market in 2021?
- What factors are affecting the strength of competition in the global generics market?
- How has the market performed over the last five years?
- How large is the global generics market in relation to its regional counterparts?
Generics Global Industry Almanac 2017-2021
Table of Contents
EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Introduction 32
What is this report about? 32
Who is the target reader? 32
How to use this report 32
Definitions 32
Global Generics 33
Market Overview 33
Market Data 34
Market Segmentation 36
Market outlook 37
Five forces analysis 39
Generics in Asia-Pacific 45
Market Overview 45
Market Data 46
Market Segmentation 48
Market outlook 49
Five forces analysis 51
Generics in Europe 57
Market Overview 57
Market Data 58
Market Segmentation 60
Market outlook 61
Five forces analysis 63
Generics in France 69
Market Overview 69
Market Data 70
Market Segmentation 72
Market outlook 73
Five forces analysis 75
Macroeconomic indicators 81
Generics in Germany 83
Market Overview 83
Market Data 84
Market Segmentation 86
Market outlook 87
Five forces analysis 89
Macroeconomic indicators 95
Generics in Australia 97
Market Overview 97
Market Data 98
Market Segmentation 100
Market outlook 101
Five forces analysis 103
Macroeconomic indicators 109
Generics in Brazil 111
Market Overview 111
Market Data 112
Market Segmentation 114
Market outlook 115
Five forces analysis 117
Macroeconomic indicators 123
Generics in Canada 125
Market Overview 125
Market Data 126
Market Segmentation 128
Market outlook 129
Five forces analysis 131
Macroeconomic indicators 137
Generics in China 139
Market Overview 139
Market Data 140
Market Segmentation 142
Market outlook 143
Five forces analysis 145
Macroeconomic indicators 152
Generics in India 154
Market Overview 154
Market Data 155
Market Segmentation 157
Market outlook 158
Five forces analysis 160
Macroeconomic indicators 166
Generics in Indonesia 168
Market Overview 168
Market Data 169
Market Segmentation 171
Market outlook 172
Five forces analysis 174
Macroeconomic indicators 180
Generics in Italy 182
Market Overview 182
Market Data 183
Market Segmentation 185
Market outlook 186
Five forces analysis 188
Macroeconomic indicators 194
Generics in Japan 196
Market Overview 196
Market Data 197
Market Segmentation 199
Market outlook 200
Five forces analysis 202
Macroeconomic indicators 208
Generics in Mexico 210
Market Overview 210
Market Data 211
Market Segmentation 213
Market outlook 214
Five forces analysis 216
Macroeconomic indicators 222
Generics in The Netherlands 224
Market Overview 224
Market Data 225
Market Segmentation 227
Market outlook 228
Five forces analysis 230
Macroeconomic indicators 236
Generics in North America 238
Market Overview 238
Market Data 239
Market Segmentation 241
Market outlook 242
Five forces analysis 244
Generics in Russia 251
Market Overview 251
Market Data 252
Market Segmentation 254
Market outlook 255
Five forces analysis 257
Macroeconomic indicators 263
Generics in Scandinavia 265
Market Overview 265
Market Data 266
Market Segmentation 268
Market outlook 269
Five forces analysis 271
Generics in Singapore 277
Market Overview 277
Market Data 278
Market Segmentation 280
Market outlook 281
Five forces analysis 283
Macroeconomic indicators 289
Generics in South Africa 291
Market Overview 291
Market Data 292
Market Segmentation 294
Market outlook 295
Five forces analysis 297
Macroeconomic indicators 303
Generics in South Korea 305
Market Overview 305
Market Data 306
Market Segmentation 308
Market outlook 309
Five forces analysis 311
Macroeconomic indicators 317
Generics in Spain 319
Market Overview 319
Market Data 320
Market Segmentation 322
Market outlook 323
Five forces analysis 325
Macroeconomic indicators 331
Generics in Turkey 333
Market Overview 333
Market Data 334
Market Segmentation 336
Market outlook 337
Five forces analysis 339
Macroeconomic indicators 345
Generics in The United Kingdom 347
Market Overview 347
Market Data 348
Market Segmentation 350
Market outlook 351
Five forces analysis 353
Macroeconomic indicators 359
Generics in The United States 361
Market Overview 361
Market Data 362
Market Segmentation 364
Market outlook 365
Five forces analysis 367
Macroeconomic indicators 373
Company Profiles 375
Leading Companies 375
Appendix 447
Methodology 447
About MarketLine 448
List of Tables
Table 1: Global generics market value: $ billion, 2012-16
Table 2: Global generics market volume: % of total pharma volume, 2012-16
Table 3: Global generics market geography segmentation: $ billion, 2016
Table 4: Global generics market value forecast: $ billion, 2016-21
Table 5: Global generics market volume forecast: % of total pharma volume, 2016-21
Table 6: Asia-Pacific generics market value: $ billion, 2012-16
Table 7: Asia-Pacific generics market volume: % of total pharma volume, 2012-16
Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2016
Table 9: Asia-Pacific generics market value forecast: $ billion, 2016-21
Table 10: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21
Table 11: Europe generics market value: $ billion, 2012-16
Table 12: Europe generics market volume: % of total pharma volume, 2012-16
Table 13: Europe generics market geography segmentation: $ billion, 2016
Table 14: Europe generics market value forecast: $ billion, 2016-21
Table 15: Europe generics market volume forecast: % of total pharma volume, 2016-21
Table 16: France generics market value: $ million, 2012-16
Table 17: France generics market volume: % of total pharma volume, 2012-16
Table 18: France generics market geography segmentation: $ million, 2016
Table 19: France generics market value forecast: $ million, 2016-21
Table 20: France generics market volume forecast: % of total pharma volume, 2016-21
Table 21: France size of population (million), 2012-16
Table 22: France gdp (constant 2005 prices, $ billion), 2012-16
Table 23: France gdp (current prices, $ billion), 2012-16
Table 24: France inflation, 2012-16
Table 25: France consumer price index (absolute), 2012-16
Table 26: France exchange rate, 2012-16
Table 27: Germany generics market value: $ million, 2012-16
Table 28: Germany generics market volume: % of total pharma volume, 2012-16
Table 29: Germany generics market geography segmentation: $ million, 2016
Table 30: Germany generics market value forecast: $ million, 2016-21
Table 31: Germany generics market volume forecast: % of total pharma volume, 2016-21
Table 32: Germany size of population (million), 2012-16
Table 33: Germany gdp (constant 2005 prices, $ billion), 2012-16
Table 34: Germany gdp (current prices, $ billion), 2012-16
Table 35: Germany inflation, 2012-16
Table 36: Germany consumer price index (absolute), 2012-16
Table 37: Germany exchange rate, 2012-16
Table 38: Australia generics market value: $ million, 2012-16
Table 39: Australia generics market volume: % of total pharma volume, 2012-16
Table 40: Australia generics market geography segmentation: $ million, 2016
Table 41: Australia generics market value forecast: $ million, 2016-21
Table 42: Australia generics market volume forecast: % of total pharma volume, 2016-21
Table 43: Australia size of population (million), 2012-16
Table 44: Australia gdp (constant 2005 prices, $ billion), 2012-16
Table 45: Australia gdp (current prices, $ billion), 2012-16
Table 46: Australia inflation, 2012-16
Table 47: Australia consumer price index (absolute), 2012-16
Table 48: Australia exchange rate, 2012-16
Table 49: Brazil generics market value: $ million, 2012-16
Table 50: Brazil generics market volume: % of total pharma volume, 2012-16
Table 51: Brazil generics market geography segmentation: $ million, 2016
Table 52: Brazil generics market value forecast: $ million, 2016-21
Table 53: Brazil generics market volume forecast: % of total pharma volume, 2016-21
Table 54: Brazil size of population (million), 2012-16
Table 55: Brazil gdp (constant 2005 prices, $ billion), 2012-16
Table 56: Brazil gdp (current prices, $ billion), 2012-16
Table 57: Brazil inflation, 2012-16
Table 58: Brazil consumer price index (absolute), 2012-16
Table 59: Brazil exchange rate, 2012-16
Table 60: Canada generics market value: $ million, 2012-16
Table 61: Canada generics market volume: % of total pharma volume, 2012-16
Table 62: Canada generics market geography segmentation: $ million, 2016
Table 63: Canada generics market value forecast: $ million, 2016-21
Table 64: Canada generics market volume forecast: % of total pharma volume, 2016-21
Table 65: Canada size of population (million), 2012-16
Table 66: Canada gdp (constant 2005 prices, $ billion), 2012-16
Table 67: Canada gdp (current prices, $ billion), 2012-16
Table 68: Canada inflation, 2012-16
Table 69: Canada consumer price index (absolute), 2012-16
Table 70: Canada exchange rate, 2012-16
Table 71: China generics market value: $ billion, 2012-16
Table 72: China generics market volume: % of total pharma volume, 2012-16
Table 73: China generics market geography segmentation: $ billion, 2016
Table 74: China generics market value forecast: $ billion, 2016-21
Table 75: China generics market volume forecast: % of total pharma volume, 2016-21
List of Figures
Figure 1: Global generics market value: $ billion, 2012-16
Figure 2: Global generics market volume: % of total pharma volume, 2012-16
Figure 3: Global generics market geography segmentation: % share, by value, 2016
Figure 4: Global generics market value forecast: $ billion, 2016-21
Figure 5: Global generics market volume forecast: % of total pharma volume, 2016-21
Figure 6: Forces driving competition in the global generics market, 2016
Figure 7: Drivers of buyer power in the global generics market, 2016
Figure 8: Drivers of supplier power in the global generics market, 2016
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2016
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2016
Figure 11: Drivers of degree of rivalry in the global generics market, 2016
Figure 12: Asia-Pacific generics market value: $ billion, 2012-16
Figure 13: Asia-Pacific generics market volume: % of total pharma volume, 2012-16
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2016
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2016-21
Figure 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2016
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2016
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2016
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2016
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2016
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2016
Figure 23: Europe generics market value: $ billion, 2012-16
Figure 24: Europe generics market volume: % of total pharma volume, 2012-16
Figure 25: Europe generics market geography segmentation: % share, by value, 2016
Figure 26: Europe generics market value forecast: $ billion, 2016-21
Figure 27: Europe generics market volume forecast: % of total pharma volume, 2016-21
Figure 28: Forces driving competition in the generics market in Europe, 2016
Figure 29: Drivers of buyer power in the generics market in Europe, 2016
Figure 30: Drivers of supplier power in the generics market in Europe, 2016
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2016
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2016
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2016
Figure 34: France generics market value: $ million, 2012-16
Figure 35: France generics market volume: % of total pharma volume, 2012-16
Figure 36: France generics market geography segmentation: % share, by value, 2016
Figure 37: France generics market value forecast: $ million, 2016-21
Figure 38: France generics market volume forecast: % of total pharma volume, 2016-21
Figure 39: Forces driving competition in the generics market in France, 2016
Figure 40: Drivers of buyer power in the generics market in France, 2016
Figure 41: Drivers of supplier power in the generics market in France, 2016
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2016
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2016
Figure 44: Drivers of degree of rivalry in the generics market in France, 2016
Figure 45: Germany generics market value: $ million, 2012-16
Figure 46: Germany generics market volume: % of total pharma volume, 2012-16
Figure 47: Germany generics market geography segmentation: % share, by value, 2016
Figure 48: Germany generics market value forecast: $ million, 2016-21
Figure 49: Germany generics market volume forecast: % of total pharma volume, 2016-21
Figure 50: Forces driving competition in the generics market in Germany, 2016
Figure 51: Drivers of buyer power in the generics market in Germany, 2016
Figure 52: Drivers of supplier power in the generics market in Germany, 2016
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2016
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2016
Figure 56: Australia generics market value: $ million, 2012-16
Figure 57: Australia generics market volume: % of total pharma volume, 2012-16
Figure 58: Australia generics market geography segmentation: % share, by value, 2016
Figure 59: Australia generics market value forecast: $ million, 2016-21
Figure 60: Australia generics market volume forecast: % of total pharma volume, 2016-21
Figure 61: Forces driving competition in the generics market in Australia, 2016
Figure 62: Drivers of buyer power in the generics market in Australia, 2016
Figure 63: Drivers of supplier power in the generics market in Australia, 2016
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Australia, 2016
Figure 65: Factors influencing the threat of substitutes in the generics market in Australia, 2016
Figure 66: Drivers of degree of rivalry in the generics market in Australia, 2016
Figure 67: Brazil generics market value: $ million, 2012-16
Figure 68: Brazil generics market volume: % of total pharma volume, 2012-16
Figure 69: Brazil generics market geography segmentation: % share, by value, 2016
Figure 70: Brazil generics market value forecast: $ million, 2016-21
Figure 71: Brazil generics market volume forecast: % of total pharma volume, 2016-21
Figure 72: Forces driving competition in the generics market in Brazil, 2016
Figure 73: Drivers of buyer power in the generics market in Brazil, 2016
Figure 74: Drivers of supplier power in the generics market in Brazil, 2016
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2016
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
